Perspective Therapeutics (CATX) Interest Coverage Ratio (2010 - 2026)
Perspective Therapeutics (CATX) posted Interest Coverage Ratio of 9.95 for Q1 2026, down 1107.27% sequentially from 0.99 in Q4 2025, and up 79.8% YoY from 5.54 in Q1 2025.
Perspective Therapeutics (CATX) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Perspective Therapeutics has reported Interest Coverage Ratio for 17 years, with the latest figure at 9.95 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 79.8% year-over-year to 9.95 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1110.32 (up 593.29% YoY) and the FY2025 annual result came in at 0.03, down 46.14% from the prior year.
- Interest Coverage Ratio eased to 9.95 in Q1 2026 per CATX's latest filing, from 0.99 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 0.99 in Q4 2025 and troughed at 1668.0 in Q4 2023.
- A 5-year average of 126.76 and a median of 9.27 in 2025 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2023 and 2025: Interest Coverage Ratio plunged 611341.74% in 2023, then soared 8489.27% in 2025.
- Over 5 years, Interest Coverage Ratio stood at 0.27 in 2022, then slumped by 611341.74% to 1668.0 in 2023, then surged by 100.0% to 0.01 in 2024, then soared by 8489.27% to 0.99 in 2025, then sank by 1107.27% to 9.95 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 9.95, 0.99, and 12.94 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | 4.82 |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 11.77 |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 10.64 |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 12.27 |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 6.48 |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | -8.96 |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 18.09 |
| 10 | Perspective Therapeutics | 388.50 Mn | 388.50 Mn | - | -412.08 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.40 |
| Mar 31, 2026 | -9.95 |
| Dec 31, 2025 | 0.99 |
| Sep 30, 2025 | -12.94 |
| Jun 30, 2025 | -9.27 |
| Mar 31, 2025 | -49.28 |
| Dec 31, 2024 | -0.01 |
| Sep 30, 2024 | -51.62 |
| Jun 30, 2024 | -52.44 |
| Mar 31, 2024 | -9.27 |
| Dec 31, 2023 | -1,668.00 |
| Sep 30, 2023 | -4.29 |
| Jun 30, 2023 | -0.71 |
| Mar 31, 2023 | -0.75 |
| Dec 31, 2022 | -0.27 |
| Mar 31, 2022 | -33.56 |
| Sep 30, 2021 | -6.63 |
| Jun 30, 2021 | 1.37 |
| Mar 31, 2021 | -0.32 |
| Dec 31, 2020 | -3.31 |